Literature DB >> 3006853

Role of the endothelium on the facilitatory effects of angiotensin I and angiotensin II on noradrenergic transmission in the caudal artery of the rat.

D F Story, J Ziogas.   

Abstract

Perfusion of carbogen gas through the lumen of the rat caudal artery abolished the dilator response to acetylcholine (1 mumol 1(-1) in artery segments which had been precontracted with noradrenaline (50 nmol 1(-1]. Hence, it was assumed that gas perfusion was effective in removing the vascular endothelium. Angiotensin I (30 nmol 1(-1] and angiotensin II (10 nmol 1(-1] enhanced the responses of artery segments to field stimulation of their sympathetic nerves (0.5 Hz, 10 s). In arteries with an intact endothelium the ability of each peptide to enhance responses to stimulation was the same whether applied through the lumen or to the adventitial surface. Removal of the endothelium, by gas perfusion, did not significantly alter the facilitatory effects of extraluminally or intraluminally applied angiotensin I or angiotensin II. The converting enzyme inhibitor enalaprilat was equally effective in inhibiting the facilitatory effect of angiotensin I in the presence and absence of an intact endothelium. It is concluded that in the rat caudal artery, conversion of angiotensin I to angiotensin II does not depend on an intact endothelium and that the facilitatory effect of angiotensin II on noradrenergic neuroeffector transmission is not modified by, or dependent on, an intact endothelium.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006853      PMCID: PMC1916900          DOI: 10.1111/j.1476-5381.1986.tb10178.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening.

Authors:  J A Fishman; G B Ryan; M J Karnovsky
Journal:  Lab Invest       Date:  1975-03       Impact factor: 5.662

2.  Subcellular localization of pulmonary antiotensin-converting enzyme (kininase II).

Authors:  J W Ryan; U S Ryan; D R Schultz; C Whitaker; A Chung
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

3.  Conversion of angiotensin I to angiotensin II in the canine mesenteric circulation.

Authors:  J DiSalvo; C B Montefusco
Journal:  Am J Physiol       Date:  1971-12

4.  The renin--angiotensin system: inhibition of converting enzyme in isolated tissues.

Authors:  J W Aiken; J R Vane
Journal:  Nature       Date:  1970-10-03       Impact factor: 49.962

Review 5.  The iso-renin angiotensin systems in extrarenal tissue.

Authors:  D Ganten; J S Hutchinson; P Schelling; U Ganten; H Fischer
Journal:  Clin Exp Pharmacol Physiol       Date:  1976 Mar-Apr       Impact factor: 2.557

6.  Effects of locally generated angiotensin II on noradrenergic transmission in guinea-pig isolated atria.

Authors:  J Ziogas; D F Story; M J Rand
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

7.  Converting enzyme activity in endothelial cells isolated from pig pulmonary artery and aorta.

Authors:  C Ody; A F Junod
Journal:  Am J Physiol       Date:  1977-03

8.  Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries.

Authors:  K U Malik; A Nasjletti
Journal:  Circ Res       Date:  1976-01       Impact factor: 17.367

9.  Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.

Authors:  A R Johnson; E G Erdös
Journal:  J Clin Invest       Date:  1977-04       Impact factor: 14.808

10.  Conversion of angiotensin I to angiotensin II.

Authors:  K K Ng; J R Vane
Journal:  Nature       Date:  1967-11-25       Impact factor: 49.962

View more
  8 in total

1.  Local formation of angiotensin II in the rat aorta: effect of endothelium.

Authors:  C Eglème; F Cressier; J M Wood
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

2.  Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, protects in vitro carbachol-induced vasorelaxation in a rat model of vascular calcium overload.

Authors:  D Henrion; J M Chillon; C Capdeville-Atkinson; M Vinceneux-Feugier; J Atkinson
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

3.  Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.

Authors:  S L Cox; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 4.  Why are converting enzyme inhibitors vasodilators?

Authors:  P M Vanhoutte; W Auch-Schwelk; M L Biondi; R R Lorenz; V B Schini; M J Vidal
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

5.  Effects of angiotensin I and angiotensin II in blood vessels: greater influence of converting enzyme activity in the rabbit basilar artery.

Authors:  A Zerrouk; M Auguet; S Delaflotte; P E Chabrier
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

6.  Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.

Authors:  F Lembeck; T Griesbacher; M Eckhardt
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

7.  Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels.

Authors:  L Chen; J R McNeill; T W Wilson; V Gopalakrishnan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Modulation by the endothelium of sympathetic vasoconstriction in an in vitro preparation of the rat tail artery.

Authors:  E Thorin; J Atkinson
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.